Dr. Pruzin is Board Certified in Neurology specializing in cognitive/behavioral neurology. He has been involved in Alzheimer’s disease research before starting medical school and continued this pursuit throughout his training. He spent three months in Medellin, Colombia during his final year of medical school interning for the Grupo de Neurociencias de Antioquia conducting research on the kindred affected by Autosomal Dominant Alzheimer’s Disease. He then completed his neurology residency at Rush University Medical Center. He investigated how diabetes influences the risk for Alzheimer’s disease, authoring original articles, a review, and a book chapter on the topic.

Dr. Pruzin moved on to a fellowship at Harvard Medical School with additional clinical training at Brigham and Women’s Hospital. He was a sub-investigator on over ten clinical trials at the Center for Alzheimer's Research and Treatment during this period. He concurrently conducted observational research with the Harvard Aging Brain Study at Massachusetts General Hospital, focusing on the intersection of vascular risk factors, physical activity, and how their interactions with AD molecular pathology influence cognitive decline and dementia. He was awarded an Alzheimer’s Association Clinical Scientist Fellowship award to continue this work.

Dr. Pruzin is an Associate Professor of Neurology at the University of Arizona College of Medicine and Banner Alzheimer’s Institute. His current research focus is modifiable risk factor interventions, especially in midlife, with the goal of reducing future risk of Alzheimer’s disease and related dementias by addressing risk factors like hypertension, diabetes, physical inactivity, and others earlier in life, when the impact of these interventions is likely to make the greatest difference in lowering future risk for dementia.

‍